• Citations Per Year
Learn More
BACKGROUND A phase II study was conducted in order to determine the toxicity and efficacy of the combination of CPT-11 and cisplatin, as salvage treatment in patients with advanced non-small-cell lung cancer (NSCLC), progressing after a docetaxel-based front-line regimen. PATIENTS AND METHODS Thirty-one patients (median age 61 years) with NSCLC, were(More)
  • 1